These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 14861023)

  • 1. NEW and nonofficial remedies: phenacemide: phenurone.
    J Am Med Assoc; 1951 Sep; 147(1):60-1. PubMed ID: 14861023
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of phenacemide (phenurone) in treatment of narcolepsy and cataplexy; a preliminary report.
    AIRD RB; GORDON NS; GREGG HC
    AMA Arch Neurol Psychiatry; 1953 Oct; 70(4):510-5. PubMed ID: 13091500
    [No Abstract]   [Full Text] [Related]  

  • 3. Phenurone in the treatment of psychomotor attacks.
    DeJONG RN
    Am J Psychiatry; 1951 May; 107(11):825-31. PubMed ID: 14829606
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of phenurone for convulsive disorders of children; preliminary report.
    KEITH HM
    Proc Staff Meet Mayo Clin; 1950 Oct; 25(21):594-5. PubMed ID: 14781222
    [No Abstract]   [Full Text] [Related]  

  • 5. Phenacemide in treatment of epilepsy.
    TYLER MW; KING EQ
    J Am Med Assoc; 1951 Sep; 147(1):17-21. PubMed ID: 14861009
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of phenurone in convulsive disorders in children.
    KEITH HM
    AMA Am J Dis Child; 1950 Nov; 80(5):719-24. PubMed ID: 14777153
    [No Abstract]   [Full Text] [Related]  

  • 7. Elevated serum creatinine levels in three patients treated with phenacemide.
    Duggan E; Hoffman L; Baska RE; Lea K; Hellerstein S
    Drug Intell Clin Pharm; 1986 Mar; 20(3):225-8. PubMed ID: 3956382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of phenylacetylurea (phenurone) in convulsive disorders.
    LITTLE SC; McBRYDE RR
    Am J Med Sci; 1950 May; 219(5):494-99. PubMed ID: 15410710
    [No Abstract]   [Full Text] [Related]  

  • 9. Phenylacetylurea in the treatment of convulsive seizures.
    CARTER S; SCIARRA D; MERRITT HH
    Trans Am Neurol Assoc; 1950; 51():255-8. PubMed ID: 14788127
    [No Abstract]   [Full Text] [Related]  

  • 10. Structure-activity relationships in the effects of phenacemide analogs on serum creatinine and anticonvulsant activity.
    Richards RK
    Arch Int Pharmacodyn Ther; 1980 Mar; 244(1):107-12. PubMed ID: 7416882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Creatinine metabolism impairment by an anticonvulsant drug, phenacemide.
    Cahen R; Martin A; Francois B; Baltassat P; Louisot P
    Ann Pharmacother; 1994 Jan; 28(1):49-51. PubMed ID: 8123960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological studies of phenacetylurea (phenurone) an anticonvulsant drug.
    EVERETT GM; RICHARDS RK
    J Pharmacol Exp Ther; 1952 Nov; 106(3):303-13. PubMed ID: 13000626
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical tests of a new anti-epileptic drug: phenylacetylurea].
    FURTADO D
    J Med (Oporto); 1955 Dec; 28(671):727-36. PubMed ID: 13278123
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of themisone and phenurone on electrically-induced seizures in the salamander.
    PETERS JJ; VONDERAHE AR
    Neurology; 1953 Dec; 3(12):890-5. PubMed ID: 13154570
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of phenacemide in epilepsy, with analysis of fatal reactions and case report.
    CRADDOCK WL
    J Am Med Assoc; 1955 Dec; 159(15):1437-41. PubMed ID: 13271091
    [No Abstract]   [Full Text] [Related]  

  • 16. [SYNTHESES OF 1-ACYL-3-PHENYLACETYLUREA DERIVATIVES].
    UMEMOTO S; OSE S; TAKAMATSU H
    Yakugaku Zasshi; 1963 Aug; 83():753-6. PubMed ID: 14087701
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of liver injury and nephrectomy on the anticonvulsant activity of phenacemide.
    WEAVER LC; SWINYARD EA; GOODMAN LS
    Proc Soc Exp Biol Med; 1952; 80(4):744-6. PubMed ID: 12983400
    [No Abstract]   [Full Text] [Related]  

  • 18. [Chemistry, pharmacology and therapeutic applications of phenylacetylurea, a new anti-epileptic substance].
    BERLINGOZZI S; MARRI R; CENTINI D; RADICCHI M; DI PACO G
    Minerva Med; 1952 Sep; 43(74):385-9. PubMed ID: 13012975
    [No Abstract]   [Full Text] [Related]  

  • 19. [PHARMACOLOGICAL STUDIES ON PHENYLCARBAMIDE DERIVATIVES WITH SPECIAL REFERENCE TO THE RELATION OF THEIR CHEMICAL STRUCTURE TO ANTICONVULSANT PROPERTIES. II. COMPARATIVE STUDIES ON PHENYLCARBAMIDE, META-TOLYCARBAMIDE AND PHENURONE].
    RUSINOV K; GEORGIEV V
    Izv Inst Fiziol (Sofiia); 1964; 7():123-32. PubMed ID: 14335492
    [No Abstract]   [Full Text] [Related]  

  • 20. Fatal aplastic anemia occurring during anticonvulsant therapy: probable idiosyncrasy to phenurone.
    SIMPSON TW; WILSON EB; ZIMMERMAN SL
    Ann Intern Med; 1950 Jun; 32(6):1224-8. PubMed ID: 15419613
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.